1. Phase II study of anti-epidermal growth factor receptor cetuximab (IM-C225) in patients with advanced pancreatic cancer;Abbruzzese;Proc Am Soc Clin Oncol,2001
2. Blocking oncogenic Ras signaling for cancer therapy;Adjei;J Natl Cancer Inst,2001
3. A phase I trial of the farnesyl transferase inhibitor SCH66336: evidence for biological and clinical activity;Adjei;Cancer Res,2000
4. A phase I trial of the farnesyl transferase inhibitor R115777, in combination with gemcitabine and cisplatin in patients with advanced cancer;Adjei;Proc Am Soc Clin Oncol,2001
5. Most human carcinomas of the exocrine pancreas contain mutant c-K-Ras genes;Almoguera;Cell,1988